Depression is a mental disorder characterized by low mood, loss of interests and pleasures, and decreased energy. It may co-occur with somatic diseases, worsening their prognosis. Depression can manifest itself in a variety of physical ailments, making it difficult to recognize. Screening tests such as HADS-M are used to diagnose depression in patients with somatic diseases. Treatment of depression includes pharmacotherapy and psychological interventions.
source: Mikołaj Majkowicz, Agata Zdun-Ryżewska “Recognition and treatment of depression in the situation of somatic illness”, Department of Psychology, Medical University of Gdańsk
Early diagnosis and treatment of depressive disorders is of great importance. If you notice a deteriorating mood in yourself or someone close to you, it is worth seeking advice from a specialist in psychiatry.
Conditions of participation:
age 18-65
the current depressive episode (deterioration of your well-being) lasts no longer than 12 months
no additional DSM-5-TR disorders: personality disorders, eating disorders, bulimia nervosa, anorexia nervosa
Additionally, we provide participants with:
reimbursement of travel expenses
complete eye examination
access to innovative treatment
medical care
You can find other benefits of participating in a clinical trial on the clinical trials home page
Duration of the study
6 weeks with the possibility of continuation in the next examination.
The total duration of participation in both studies is approximately 60 weeks (13.8 months).
Join us!
Principal Investigator
lek. Ewa Tylko
